GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (FRA:OC50) » Definitions » Moat Score

Cochlear (FRA:OC50) Moat Score : 7/10 (As of Jul. 20, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Cochlear Moat Score?

Cochlear has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Cochlear has Wide Moat: Cochlear Ltd has a leading market position in hearing implants, supported by strong brand recognition and significant customer switching costs. The company benefits from valuable patents, a robust distribution network, and consistent innovation, providing durable competitive advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Cochlear might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Competitive Comparison of Cochlear's Moat Score

For the Medical Devices subindustry, Cochlear's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cochlear's Moat Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cochlear's Moat Score distribution charts can be found below:

* The bar in red indicates where Cochlear's Moat Score falls into.


;
;

Cochlear  (FRA:OC50) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Cochlear Moat Score Related Terms

Thank you for viewing the detailed overview of Cochlear's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Cochlear Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (FRA:OC50) » Definitions » Moat Score
Comparable Companies
ASX:PNV ASX:IMR ASX:ARX ASX:EMV ASX:SOM ASX:4DX ASX:IPD ASX:COV ASX:CMP ASX:CSX ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE XAMS:PHIA
Traded in Other Exchanges
CHEOY:USA CHEOF:USA OC5:Germany COH:Australia
Address
1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Website
https://www.cochlear.com
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.

Cochlear Headlines

No Headlines